A detailed history of Pilgrim Partners Asia Pte LTD transactions in Moderna, Inc. stock. As of the latest transaction made, Pilgrim Partners Asia Pte LTD holds 1,600 shares of MRNA stock, worth $48,864. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,600
Holding current value
$48,864
% of portfolio
0.06%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$36.85 - $63.93 $58,960 - $102,288
1,600 New
1,600 $66.5 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $11.9B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Pilgrim Partners Asia Pte LTD Portfolio

Follow Pilgrim Partners Asia Pte LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pilgrim Partners Asia Pte LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pilgrim Partners Asia Pte LTD with notifications on news.